Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Key Appointment At MSD China Shows Long-Term Investment

This article was originally published in PharmAsia News

Executive Summary

Merck, Sharpe & Dohme recently appointed health care veteran Michel Vounatsos as MSD China president. Before coming to China, he was president of MSD France, one of the firm's most important markets outside the U.S. The current appointment shows the company's long-term investment and commitment in China as well as the country's strategic importance for MSD. Vounatsos said China is a key market for MSD; the firm will continue to provide innovative drugs and services for Chinese customers as well as offer full support to the nation's health care reform. (Click here for more - Chinese language)
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC070798

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel